Drug intelligence / Profile preview

oxidized recombinant human galectin-1

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes
Administration
Local (peripheral Application At Surgical Site)
01

Overview

Oxidized recombinant human galectin-1 is a modified form of the protein galectin-1 produced via recombinant DNA technology. Galectin-1 is a member of the beta-galactoside-binding lectin family and plays key roles in cell-cell and cell-matrix interactions, immune regulation, apoptosis, and tissue repair. In its oxidized state—characterized by the formation of disulfide bonds between cysteine residues—galectin-1 loses its carbohydrate-binding (lectin) activity but gains new biological functions. Notably, oxidized recombinant human galectin-1 has been shown to promote axonal regeneration and enhance functional recovery after peripheral nerve injury in animal models. It increases both the number and diameter of regenerating myelinated fibers at sites distal to nerve transection[1][4][9]. The protein’s redox-dependent switch alters its structure and function; while reduced forms bind carbohydrates on cell surfaces to modulate immune responses or tumor progression[2], oxidation leads to loss of lectin activity but acquisition of neuroregenerative properties[5]. Recombinant production typically uses E. coli expression systems for research purposes.

Other names
oxidized galectin-1rhGAL-1/OxLGALS1 (oxidized form)
02

Targets

Beta-galactoside-containing glycans

Beyond the preview

Go deeper on oxidized recombinant human galectin-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxidized recombinant human galectin-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call